NIH Director's Blog: Drug Development

OCTOBER 11, 2022

Barry Sharpless, Scripps Research, La Jolla, CA, October 5, 2022 marked the second time that he’s received an early-morning congratulatory call from The Royal Swedish Academy of Sciences. 2001, 40 (11), 2004–2021 [2] A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “Llgation” of azides and terminal alkynes.

Research 52

Research Small Molecule Science Clinical Research 52

Drug Discovery World

OCTOBER 16, 2023

This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture. It has a vibrant community of life-science companies, from global pharma to smaller start-ups.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

The Pharma Data

DECEMBER 15, 2020

SH) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. .” About CHIPSCREEN BIOSCIENCES. Shenzhen Chipscreen Biosciences Co., Chipscreen Biosciences, Stock Symbol: 688321.SH)

Pharmaceuticals 40

Pharmaceuticals Small Molecule Clinical Trials Production 40

Drug Discovery World

OCTOBER 7, 2022

This funding is distributed between funding discovery research at our core institutes, and at universities around the UK, clinical research, cancer grand challenges, and translational research. . Recent studies have shown that academic inventors contributed 37% of cancer medicines between 2001-2019.

Pharma Companies 130

Pharma Companies Science Research Drug Development 130

The Pharma Data

JANUARY 10, 2021

SH ) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. About CHIPSCREEN BIOSCIENCES. Shenzhen Chipscreen Biosciences Co., Chipscreen Biosciences, Stock Symbol: 688321.

Clinical Trials 52

Clinical Trials Treatment Trials Small Molecule 52